Rthp-20. evaluation of radiation therapy technology and dosimetry impact on treatment outcome for glioblastoma patients
CONCLUSION:Average brain and brainstem dose as well as BTV were strongly associated with OS, and might aid prognostication. VMAT and IGRT technology allowed for reduction of doses to healthy brain, including the hippocampi, which may reduce toxicity and preserve cognition. The benefit of VMAT and IGRT technology was not offset by a reduction of PFS or OS.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Rosenschold, P. M. a., Law, I., Engelholm, S. A., Muhic, A., Lundemann, M., Roed, H., Grunnet, K., Poulsen, H. S. Tags: RADIATION THERAPY Source Type: research
More News: Brain | Brain Cancers | Cancer & Oncology | Neurology | PET Scan | Radiation Therapy | Statistics | Temodar | Toxicology